验证数据展示
经过测试的应用
Positive IF-P detected in | human colon cancer tissue |
Positive IF/ICC detected in | HepG2 cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
CL488-60044 targets Transgelin 2 in IF/ICC, IF-P applications and shows reactivity with human, mouse samples.
经测试应用 | IF/ICC, IF-P Application Description |
经测试反应性 | human, mouse |
免疫原 | Transgelin 2 fusion protein Ag0337 种属同源性预测 |
宿主/亚型 | Mouse / IgG1 |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | transgelin 2 |
别名 | TAGLN2, Transgelin 2/TAGLN2, SM22-alpha homolog, Epididymis tissue protein Li 7e, CDABP0035 |
计算分子量 | 199 aa, 22 kDa |
观测分子量 | 22 kDa |
GenBank蛋白编号 | BC002616 |
基因名称 | Transgelin-2/TAGLN2 |
Gene ID (NCBI) | 8407 |
RRID | AB_3084132 |
偶联类型 | CoraLite® Plus 488 Fluorescent Dye |
最大激发/发射波长 | 493 nm / 522 nm |
形式 | Liquid |
纯化方式 | Protein G purification |
UNIPROT ID | P37802 |
储存缓冲液 | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3 |
储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
The transgelin family is a group of proteins that belong to 22 kDa actin-related corpnin superfamily. Of all three isoforms, transgelin 1 is the best characterized. Transgelin 1, also known as SM22 alpha, is a specific marker for differentiated smooth muscle cells. Transgelin 2, also known as SM22 beta, is expressed by both smooth muscle and non-smooth muscle cells in a temporally and spatially regulated pattern. Trangenlin 3, also known as NP25, is only found in highly differentiated neuronal cells. Our test result showed that this antibody Is specific to TAGLN2. It does not bind TAGLN1 and TAGLN3.
实验方案
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 Transgelin 2 antibody CL488-60044 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |